Roche buys US NimbleGen for 272.5 mln usd UPDATE |
|
|
|
Published
:
Tue, 19 Jun 2007 07:31
|
(Adds details on acquisition)ZURICH (Thomson Financial) - Roche Holdings AG said it has agreed to acquire NimbleGen Systems -- a US-based company active in high-density DNA microarrays -- for 272.5 mln usd.The deal is expected to close in the third quarter of 2007 and remains subject to regulatory approval.NimbleGen will become a fully integrated part of Roche Applied Science, part of the group's diagnostic division, the Swiss pharma group said.Roche said the deal allows it to enter the high-growth research microarrray market, which is estimated to be worth 600 mln usd worldwide and growing by 10 pct annually.The move will also strengthen its presence in the genomics research market, Roche said.DNA microarrays are a widely used discovery and research tool in pharma research for the understanding of genetic causes of disease and predisposition factors, comparative genomic analysis and identification of potential drug targets.johanna.treeck@thomson.comjmt/jfr/sf/bsdCOPYRIGHTCopyright AFX News Limited 2007. All rights reserved.The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
1398.07 |
-137.50 (
-8.95 %)
|
| SYMBOL (
2007-09-26 ) |
| LAST |
CHANGE
|
|
HANSON
(
12:41pm )
|
|
1099.00 |
+3.00 (
0.27 %)
|
|
AMVESCAP
(
11:35am )
|
|
607.50 |
+2.50 (
0.41 %)
|
| SYMBOL (
2008-12-01 )
|
| LAST |
CHANGE
|
|
INTEL CP
(
4:00pm ) |
|
12.56 |
-1.24 (
-9.16 %)
|
| SYMBOL (
2007-09-04 )
|
| LAST |
CHANGE
|
|
|
Print this Story
Roche buys US Nimblegen for 272.5 mln usd 